Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy

References

• Angsantikul P, Thamphiwatana S, Zhang Q, et al. (2018). Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection. Adv Ther 1:201800016.
   Google Scholar
• Anitua E, Andia I, Ardanza B, et al. (2004). Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91:4–15.
   PubMed Web of Science ®Google Scholar
• Arulselvan P, Tan WS, Gothai S, et al. (2016). Anti-inflammatory potential of ethyl acetate fraction of moringa oleifera in downregulating the NF-κB signaling pathway in lipopolysaccharide-stimulated macrophages. Molecules 21:1452.
   PubMed Web of Science ®Google Scholar
• Berikkhanova K, Omarbaev R, Gulyayev A, et al. (2016). Red blood cell ghosts as promising drug carriers to target wound infections. Med Eng Phys 38:877–84.
   PubMed Web of Science ®Google Scholar
• Boada C, Zinger A, Tsao C, et al. (2019). Rapamycin-loaded biomimetic nanoparticles reverse vascular inflammation. Circ Res 126:25–37.
   PubMed Web of Science ®Google Scholar
• Bobo D, Robinson KJ, Islam J, et al. (2020). Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm Res 33:2373–87.
   Google Scholar
• Bose RJ, Kim BJ, Arai Y, et al. (2018). Bioengineered stem cell membrane functionalized nanocarriers for therapeutic targeting of severe hindlimb ischemia. Biomaterials 185:360–70.
   PubMed Web of Science ®Google Scholar
• Campbell EM, Hope TJ. (2015). HIV-1 capsid: the multifaceted key player in HIV-1 infection. Nat Rev Microbiol 13:471–83.
   PubMed Web of Science ®Google Scholar
• Cao H, Dan Z, He X, et al. (2016). Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano 10:7738–48.
   PubMed Web of Science ®Google Scholar
• Chamberlain G, Fox J, Ashton B, et al. (2007). Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25:2739–49.
   PubMed Web of Science ®Google Scholar
• Choi B, Park W, Park SB, et al. (2020). Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications. Methods 177:2–14.
   PubMed Web of Science ®Google Scholar
• De Stoppelaar SF, Van’t Veer C, Van der Poll T. (2014). The role of platelets in sepsis. Thromb Haemost 112:666–77.
   PubMed Web of Science ®Google Scholar
• Dehaini D, Wei X, Fang RH, et al. (2017). Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater 29:1606209.
   Web of Science ®Google Scholar
• Dodson MV, Hausman GJ, Guan L, et al. (2010). Skeletal muscle stem cells from animals I. basic cell biology. Int J Bio Sci 6:465–74.
   Google Scholar
• Dong X, Chu D, Wang Z. (2017). Leukocyte-mediated delivery of nanotherapeutics in inflammatory and tumor sites. Theranostics 7:751–63.
   PubMed Web of Science ®Google Scholar
• Dong X, Gao J, Zhang ZY, et al. (2019). Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke. ACS Nano 13:1272–83.
   PubMed Web of Science ®Google Scholar
• Doshi N, Orje JN, Molins B, et al. (2012). Platelet mimetic particles for targeting thrombi in flowing blood. Adv Mater 24:3864–9.
   PubMed Web of Science ®Google Scholar
• Esteban-Fernández de Ávila B, Angsantikul P, Ramírez-Herrera DE, et al. (2018). Hybrid biomembrane-functionalized nanorobots for concurrent removal of pathogenic bacteria and toxins. Sci Robot 3:0485.
   Web of Science ®Google Scholar
• Etulain J. (2018). Platelets in wound healing and regenerative medicine. Platelets 29:556–68.
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu CM, Luk BT, et al. (2014). Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett 14:2181–8.
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu CM, Zhang L. (2012). Nanoparticles disguised as red blood cells to evade the immune system. Expert Opin Biol Ther 12:385–9.
   PubMed Web of Science ®Google Scholar
• Fisher JF, Mobashery S. (2020). Constructing and deconstructing the bacterial cell wall. Protein Sci 29:629–46.
   PubMed Web of Science ®Google Scholar
• Gagliardi M. (2017). Biomimetic and bioinspired nanoparticles for targeted drug delivery. Ther Deliv 8:289–99.
   PubMed Web of Science ®Google Scholar
• Gao C, Lin Z, Jurado-Sánchez B, et al. (2016). Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery. Small 12:4056–62.
   PubMed Web of Science ®Google Scholar
• Gao J, Chu D, Wang Z. (2016). Cell membrane-formed nanovesicles for disease-targeted delivery. J Control Release 224:208–16.
   PubMed Web of Science ®Google Scholar
• Gao J, Dong X, Su Y, et al. (2021). Human neutrophil membrane-derived nanovesicles as a drug delivery platform for improved therapy of infectious diseases. Acta Biomater 123:354–63.
   PubMed Web of Science ®Google Scholar
• Gao J, Wang S, Dong X, et al. (2020). Co-delivery of resolvin D1 and antibiotics with nanovesicles to lungs resolves inflammation and clears bacteria in mice. Commun Biol 3:680.
   PubMed Web of Science ®Google Scholar
• Gao J, Wang S, Wang Z. (2017). High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy. Biomaterials 135:62–73.
   PubMed Web of Science ®Google Scholar
• Gao W, Fang RH, Thamphiwatana S, et al. (2015). Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. Nano Lett 15:1403–9.
   PubMed Web of Science ®Google Scholar
• Guo P, Huang J, Zhao Y, et al. (2018). Nanomaterial preparation by extrusion through nanoporous membranes. Small 14:1703493.
   PubMed Web of Science ®Google Scholar
• Han Y, Zhao R, Xu F. (2018). Neutrophil-based delivery systems for nanotherapeutics. Small 14:1801674.
   PubMed Web of Science ®Google Scholar
• Hao X, Li Q, Wang H, et al. (2018). Red-blood-cell-mimetic gene delivery systems for long circulation and high transfection efficiency in ECs. J Mater Chem B Mater Biol Med 6:5975–85.
   PubMed Web of Science ®Google Scholar
• Harris JC, Scully MA, Day ES. (2019). Cancer cell membrane-coated nanoparticles for cancer management. Cancers 11:1836.
   PubMed Web of Science ®Google Scholar
• He Y, Li R, Liang J, et al. (2018). Drug targeting through platelet membrane-coated nanoparticles for the treatment of rheumatoid arthritis. Nano Res 11:6086–101.
   Web of Science ®Google Scholar
• Holst J, Martin D, Arnold R, et al. (2009). Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine 27:B3–12.
   PubMed Web of Science ®Google Scholar
• Hoshyar N, Gray S, Han H, et al. (2016). The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine 11:673–92.
   PubMed Web of Science ®Google Scholar
• Hou XL, Tong Q, Wang WQ, et al. (2015). Suppression of inflammatory responses by dihydromyricetin, a flavonoid from ampelopsis grossedentata, via inhibiting the activation of NF-κB and MAPK signaling pathways. J Nat Prod 78:1689–96.
   PubMed Web of Science ®Google Scholar
• Hu CM, Fang RH, Luk BT, et al. (2013). 'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. Nanoscale 5:2664–8.
   PubMed Web of Science ®Google Scholar
• Hu CM, Fang RH, Luk BT, et al. (2013). Nanoparticle-detained toxins for safe and effective vaccination. Nat Nanotechnol 8:933–8.
   PubMed Web of Science ®Google Scholar
• Hu CM, Fang RH, Wang KC, et al. (2015). Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526:118–21.
   PubMed Web of Science ®Google Scholar
• Hu CM, Fang RH, Zhang L. (2012). Erythrocyte-inspired delivery systems. Adv Healthc Mater 1:537–47.
   PubMed Web of Science ®Google Scholar
• Hu CM, Zhang L, Aryal S, et al. (2011). Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA 108:10980–5.
   PubMed Web of Science ®Google Scholar
• Huang Y, Gao X, Chen J. (2018). Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy. Acta Pharm Sin B 8:4–13.
   PubMed Web of Science ®Google Scholar
• Hwang DW, Choi H, Jang SC, et al. (2015). Noninvasive imaging of radiolabeled exosome-mimetic nanovesicle using 99mTc-HMPAO. Sci Rep 5:15636.
   PubMed Web of Science ®Google Scholar
• Karp JM, Leng Teo GS. (2009). Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4:206–16.
   PubMed Web of Science ®Google Scholar
• Kim OY, Choi SJ, Jang SC, et al. (2015). Bacterial protoplast-derived nanovesicles as vaccine delivery system against bacterial infection. Nano Lett 15:266–74.
   PubMed Web of Science ®Google Scholar
• Kolaczkowska E, Kubes P. (2013). Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13:159–75.
   PubMed Web of Science ®Google Scholar
• Kononenko V, Narat M, Drobne D. (2015). Nanoparticle interaction with the immune system. Arh Hig Rada Toksikol 66:97–108.
   PubMed Web of Science ®Google Scholar
• Koo J, Escajadillo T, Zhang L, et al. (2019). Erythrocyte-coated nanoparticles block cytotoxic effects of Group B Streptococcus β-hemolysin/cytolysin. Front Pediatr 7:410.
   PubMed Web of Science ®Google Scholar
• Krassowska W, Filev PD. (2007). Modeling electroporation in a single cell. Biophys J 92:404–17.
   PubMed Web of Science ®Google Scholar
• Li LL, Xu JH, Qi GB, et al. (2014). Core-shell supramolecular gelatin nanoparticles for adaptive and “on-demand” antibiotic delivery. ACS Nano 8:4975–83.
   PubMed Web of Science ®Google Scholar
• Li S, Zeng YC, Peng K, et al. (2019). Design and evaluation of glomerulus mesangium-targeted PEG-PLGA nanoparticles loaded with dexamethasone acetate. Acta Pharmacol Sin 40:143–50.
   PubMed Web of Science ®Google Scholar
• Li Z, Hu S, Cheng K. (2018). Platelets and their biomimetics for regenerative medicine and cancer therapies. J Mater Chem B Mater Biol Med 6:7354–65.
   PubMed Web of Science ®Google Scholar
• Liang H, Huang K, Su T, et al. (2018). Mesenchymal stem cell/red blood cell-inspired nanoparticle therapy in mice with carbon tetrachloride-induced acute liver failure. ASC Nano 12:6536–44.
   Web of Science ®Google Scholar
• Luk BT, Hu CM, Fang RH, et al. (2014). Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale 6:2730–7.
   PubMed Web of Science ®Google Scholar
• Luk BT, Zhang L. (2015). Cell membrane-camouflaged nanoparticles for drug delivery. J Control Release 220:600–7.
   PubMed Web of Science ®Google Scholar
• Lv W, Xu J, Wang X, et al. (2018). Bioengineered boronic ester modified dextran polymer nanoparticles as reactive oxygen species responsive nanocarrier for ischemic stroke treatment. ACS Nano 12:5417–26.
   PubMed Web of Science ®Google Scholar
• May AE, Seizer P, Gawaz M. (2008). Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 28:5–10.
   PubMed Web of Science ®Google Scholar
• Metselaar JM, Wauben MH, Wagenaar-Hilbers JP, et al. (2003). Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum 48:2059–66.
   PubMed Web of Science ®Google Scholar
• Mitchell MJ, King MR. (2015). Leukocytes as carriers for targeted cancer drug delivery. Expert Opin Drug Deliv 12:375–92.
   PubMed Web of Science ®Google Scholar
• Molinaro R, Corbo C, Martinez JO, et al. (2016). Biomimetic proteolipid vesicles for targeting inflamed tissues. Nat Mater 15:1037–46.
   PubMed Web of Science ®Google Scholar
• Morrell CN, Aggrey AA, Chapman LM, et al. (2014). Emerging roles for platelets as immune and inflammatory cells. Blood 123:2759–67.
   PubMed Web of Science ®Google Scholar
• Muzykantov VR. (2010). Drug delivery by red blood cells: vascular carriers designed by mother nature. Expert Opin Drug Deliv 7:403–27.
   PubMed Web of Science ®Google Scholar
• Nasef NA, Mehta S, Ferguson LR. (2017). Susceptibility to chronic inflammation: an update. Arch Toxicol 91:1131–41.
   PubMed Web of Science ®Google Scholar
• Oieni J, Levy L, Khait NL, et al. (2020). Nano-ghosts: biomimetic membranal vesicles, technology and characterization. Methods 177:126–34.
   PubMed Web of Science ®Google Scholar
• Oishi Y, Manabe I. (2018). Macrophages in inflammation, repair and regeneration. Int Immunol 30:511–28.
   PubMed Web of Science ®Google Scholar
• Parodi A, Quattrocchi N, van de Ven AL, et al. (2013). Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol 8:61–8.
   PubMed Web of Science ®Google Scholar
• Ping Y, Hu X, Yao Q, et al. (2016). Engineering bioinspired bacteria-adhesive clay nanoparticles with a membrane-disruptive property for the treatment of Helicobacter pylori infection. Nanoscale 8:16486–98.
   PubMed Web of Science ®Google Scholar
• Qin A, Coffey DG, Warren EH, et al. (2016). Mechanisms of immune evasion and current status of checkpoint inhibitors in non-small cell lung cancer. Cancer Med 5:2567–78.
   PubMed Web of Science ®Google Scholar
• Rao L, Cai B, Bu LL, et al. (2017). Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy. ACS Nano 11:3496–505.
   PubMed Web of Science ®Google Scholar
• Rao L, Wu L, Liu Z, et al. (2020). Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis. Nat Commun 11:4909.
   PubMed Web of Science ®Google Scholar
• Ren X, Zheng R, Fang X, et al. (2016). Red blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal therapy. Biomaterials 92:13–24.
   PubMed Web of Science ®Google Scholar
• Rennert RC, Sorkin M, Garg RK, et al. (2012). Stem cell recruitment after injury: lessons for regenerative medicine. Regen Med 7:833–50.
   PubMed Web of Science ®Google Scholar
• Rossi L, Fraternale A, Bianchi M, et al. (2019). Red blood cell membrane processing for biomedical applications. Front Physiol 10:1070.
   PubMed Web of Science ®Google Scholar
• Serebrovska Z, Swanson RJ, Portnichenko V, et al. (2017). Anti-inflammatory and antioxidant effect of cerium dioxide nanoparticles immobilized on the surface of silica nanoparticles in rat experimental pneumonia. Biomed Pharmacother 92:69–77.
   PubMed Web of Science ®Google Scholar
• Shi J, Ma Y, Zhu J, et al. (2018). A review on electroporation-based intracellular delivery. Molecules 23:3044.
   PubMed Web of Science ®Google Scholar
• Song Y, Huang Z, Liu X, et al. (2019). Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE–/–) mice. Nanomedicine 15:13–24.
   PubMed Web of Science ®Google Scholar
• Sonnenberg GF, Artis D. (2015). Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat Med 21:698–708.
   PubMed Web of Science ®Google Scholar
• Sridharan R, Cameron AR, Kelly DJ, et al. (2015). Biomaterial based modulation of macrophage polarization: a review and suggested design principles. Mater Today 18:313–25.
   Web of Science ®Google Scholar
• Su J, Sun H, Meng Q, et al. (2016). Long circulation red-blood-cell-mimetic nanoparticles with peptide-enhanced tumor penetration for simultaneously inhibiting growth and lung metastasis of breast cancer. Adv Funct Mater 26:1243–52.
   Web of Science ®Google Scholar
• Tabas I, Glass CK. (2013). Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339:166–72.
   PubMed Web of Science ®Google Scholar
• Tan S, Wu T, Zhang D, et al. (2015). Cell or cell membrane-based drug delivery systems. Theranostics 5:863–81.
   PubMed Web of Science ®Google Scholar
• Tang J, Shen D, Caranasos TG, et al. (2017). Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat Commun 8:13724.
   PubMed Web of Science ®Google Scholar
• Tarek M. (2017). Atomistic simulations of electroporation of model cell membranes. Adv Anat Embryol Cell Biol 227:1–15.
   PubMed Web of Science ®Google Scholar
• Thamphiwatana S, Angsantikul P, Escajadillo T, et al. (2017). Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management. Proc Natl Acad Sci USA 114:11488–93.
   PubMed Web of Science ®Google Scholar
• van Meer G. (2011). Dynamic transbilayer lipid asymmetry. Cold Spring Harb Perspect Biol 3:1–11.
   Web of Science ®Google Scholar
• Vijayan V, Uthaman S, Park IK. (2018). Cell membrane coated nanoparticles: an emerging biomimetic nanoplatform for targeted bioimaging and therapy. Adv Exp Med Biol 1064:45–59.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang Y, Zhang L, et al. (2018). Pretreated macrophage-membrane-coated gold nanocages for precise drug delivery for treatment of bacterial infections. Adv Mater 30:1804023.
   PubMed Web of Science ®Google Scholar
• Wang H, Wu J, Williams GR, et al. (2019). Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery. J Nanobiotechnology 17:60.
   PubMed Web of Science ®Google Scholar
• Wang S, Gao J, Li M, et al. (2018). A facile approach for development of a vaccine made of bacterial double-layered membrane vesicles (DMVs). Biomaterials 187:28–38.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang K, Qin X, et al. (2019). Biomimetic nanotherapies: red blood cell based core-shell structured nanocomplexes for atherosclerosis management. Adv Sci 6:1900172.
   Web of Science ®Google Scholar
• Wei X, Gao J, Fang RH, et al. (2016). Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia. Biomaterials 111:116–23.
   PubMed Web of Science ®Google Scholar
• Wei X, Zhang G, Ran D, et al. (2018). T-cell-mimicking nanoparticles can neutralize HIV infectivity. Adv Mater 30:1802233.
   PubMed Web of Science ®Google Scholar
• Wu HH, Zhou Y, Tabata Y, et al. (2019). Mesenchymal stem cell-based drug delivery strategy: from cells to biomimetic. J Control Release 294:102–13.
   PubMed Web of Science ®Google Scholar
• Xia Q, Zhang Y, Li Z, et al. (2019). Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application. Acta Pharm Sin B 9:675–89.
   PubMed Web of Science ®Google Scholar
• Yang J, Wang F, Lu Y, et al. (2019). Recent advance of erythrocyte-mimicking nanovehicles: from bench to bedside. J Control Release 314:81–91.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Su J, Ran W, et al. (2017). Preparation and application of cell membrane-camouflaged nanoparticles for cancer therapy. Theranostics 7:2575–92.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Dehaini D, Zhang Y, et al. (2018). Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat Nanotechnol 13:1182–90.
   PubMed Web of Science ®Google Scholar
• Zhang X, Qiu M, Guo P, et al. (2018). Autologous red blood cell delivery of betamethasone phosphate sodium for long anti-inflammation. Pharmaceutics 10:286.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen Y, Lo C, et al. (2019). Inhibition of pathogen adhesion by bacterial outer membrane-coated nanoparticles. Angew Chem Int Ed Engl 58:11404–8.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Chen W, et al. (2017). Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection. J Control Release 263:185–91.
   PubMed Web of Science ®Google Scholar